$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Oct 24, 2025)
$657.23M
Market Cap
-
P/E Ratio
-3.24
EPS
$17.00
52 Week High
$2.68
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Replimune Group, Inc., headquartered in Woburn, Massachusetts, is at the forefront of biotechnology, specializing in the development of oncolytic immunotherapies aimed at revolutionizing cancer treatment. Utilizing its proprietary Immuno-Oncology platform, the company targets cancer cells with precision while enhancing the body's immune response against tumors. Replimune's advancing clinical programs demonstrate the potential effectiveness of its innovative therapies, establishing it as a key player in the dynamic oncology landscape. With a strong commitment to transforming cancer care, Replimune is well-positioned for significant growth and impact in the industry.
BYND
WGRX
VHAI
YYAI
F
ASST
INTC
DVLT
CGBS
NVDA
BITF
TSLA
AAL
DNN
RGTI
NEUP
ADTX
PLUG
T
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
TLRY
QS
ADAP
SNAP
CIFR
AIRE
JOBY
RXRX
BAC
NIO
IREN
BTBT
RR
AMC
NVTS
PLTR
CLOV
UUUU
DFLI
RVPH
MARA
KDLY
APLD
PBR
WU
GOOGL
SOUN
IONQ
VZ
PFE
WULF
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD
BYND
WGRX
VHAI
YYAI
F
ASST
INTC
DVLT
CGBS
NVDA
BITF
TSLA
AAL
DNN
RGTI
NEUP
ADTX
PLUG
T
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
TLRY
QS
ADAP
SNAP
CIFR
AIRE
JOBY
RXRX
BAC
NIO
IREN
BTBT
RR
AMC
NVTS
PLTR
CLOV
UUUU
DFLI
RVPH
MARA
KDLY
APLD
PBR
WU
GOOGL
SOUN
IONQ
VZ
PFE
WULF
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD